| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.761 | 0.003 | 0.761 | Non-steroidal antiinflammatory agent | 0.598 0.004 CID_44266508 0.759 0.003 CID_44266438 | ||
| 0.692 | 0.003 | 0.692 | Cyclooxygenase inhibitor | 0.624 0.004 CID_44266508 0.643 0.004 CID_44266438 | ||
| 0.652 | 0.003 | 0.652 | Cyclooxygenase 2 inhibitor | 0.578 0.004 CID_44266508 0.597 0.004 CID_44266438 | ||
| 0.546 | 0.005 | 0.546 | Cyclooxygenase 1 inhibitor | 0.464 0.005 CID_44266508 0.511 0.005 CID_44266438 | ||
| 0.589 | 0.057 | 0.622 | Antiinflammatory | 0.53 0.076 CID_44266508 0.622 0.048 CID_44266438 | CID_44266438 | |
| 0.461 | 0.04 | 0.649 | Toll-Like receptor 7 agonist | 0.649 0.012 CID_44266508 0.538 0.025 CID_44266438 | CID_44266508 | |
| 0.454 | 0.042 | 0.641 | Toll-Like receptor agonist | 0.641 0.013 CID_44266508 0.533 0.026 CID_44266438 | CID_44266508 | |
| 0.432 | 0.031 | 0.432 | Nootropic | 0.368 0.048 CID_44266508 0.362 0.05 CID_44266438 | ||
| 0.429 | 0.043 | 0.429 | MAP kinase kinase 6 inhibitor | 0.417 0.049 CID_44266508 0.306 0.129 CID_44266438 | ||
| 0.434 | 0.054 | 0.488 | Antiobesity | 0.488 0.04 CID_44266438 | CID_44266438 | |
| 0.438 | 0.069 | 0.438 | Analgesic | 0.282 0.156 CID_44266508 0.335 0.117 CID_44266438 | ||
| 0.406 | 0.088 | 0.535 | Cyclophilin D inhibitor | 0.48 0.056 CID_44266508 0.535 0.041 CID_44266438 | CID_44266438 | |
| 0.32 | 0.03 | 0.32 | EphB2 antagonist | 0.181 0.102 CID_44266508 0.211 0.08 CID_44266438 | ||
| 0.303 | 0.014 | 0.39 | Heat shock protein 90 alpha antagonist | 0.39 0.005 CID_44266508 0.191 0.055 CID_44266438 | CID_44266508 | |
| 0.328 | 0.041 | 0.328 | Potassium channel (Voltage-sensitive) blocker | 0.174 0.117 CID_44266438 | ||
| 0.294 | 0.012 | 0.294 | MAP kinase 9 inhibitor | 0.143 0.04 CID_44266508 0.156 0.035 CID_44266438 | ||
| 0.289 | 0.014 | 0.289 | Insulin secretagoues | 0.278 0.015 CID_44266508 0.247 0.02 CID_44266438 | ||
| 0.319 | 0.044 | 0.319 | HERG channel blocker | 0.141 0.14 CID_44266508 0.174 0.107 CID_44266438 | ||
| 0.271 | 0.007 | 0.271 | Aurora-C kinase inhibitor | 0.222 0.014 CID_44266508 0.266 0.008 CID_44266438 | ||
| 0.263 | 0.007 | 0.556 | Phosphodiesterase IV inhibitor | 0.556 0.003 CID_44266508 0.315 0.005 CID_44266438 | CID_44266508 | |
| 0.314 | 0.066 | 0.314 | 5 Hydroxytryptamine release stimulant | 0.183 0.137 CID_44266508 0.311 0.066 CID_44266438 | ||
| 0.241 | 0.005 | 0.369 | Phosphodiesterase 4B inhibitor | 0.369 0.004 CID_44266508 0.301 0.005 CID_44266438 | CID_44266508 | |
| 0.23 | 0.008 | 0.23 | Hedgehog signaling inhibitor | 0.105 0.056 CID_44266508 0.177 0.015 CID_44266438 | ||
| 0.255 | 0.035 | 0.255 | LIM domain kinase 1 inhibitor | 0.139 0.11 CID_44266438 | ||
| 0.224 | 0.006 | 0.224 | Pregnane X receptor agonist | 0.171 0.025 CID_44266508 0.187 0.015 CID_44266438 | ||
| 0.235 | 0.024 | 0.235 | Activin receptor-like kinase 2 inhibitor | 0.173 0.051 CID_44266438 | ||
| 0.213 | 0.012 | 0.213 | Activin receptor-like kinase 4 inhibitor | 0.11 0.067 CID_44266508 0.112 0.063 CID_44266438 | ||
| 0.28 | 0.079 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.229 0.127 CID_44266438 | ||
| 0.214 | 0.034 | 0.241 | Interleukin 6 antagonist | 0.241 0.025 CID_44266508 0.188 0.048 CID_44266438 | CID_44266508 | |
| 0.195 | 0.017 | 0.195 | MAP kinase 8 inhibitor | 0.116 0.046 CID_44266508 0.129 0.038 CID_44266438 | ||
| 0.181 | 0.013 | 0.256 | Phosphodiesterase 4D inhibitor | 0.256 0.007 CID_44266508 0.136 0.023 CID_44266438 | CID_44266508 | |
| 0.197 | 0.031 | 0.197 | Sodium channel (voltage-gated) blocker | 0.177 0.039 CID_44266438 | ||
| 0.241 | 0.076 | 0.241 | Dyrk kinase inhibitor | 0.203 0.097 CID_44266438 | ||
| 0.163 | 0.004 | 0.164 | G protein-coupled receptor agonist | 0.062 0.012 CID_44266508 0.164 0.004 CID_44266438 | CID_44266438 | |
| 0.178 | 0.02 | 0.178 | Potassium channel (Ca-activated) activator | 0.095 0.06 CID_44266508 0.099 0.056 CID_44266438 | ||
| 0.164 | 0.006 | 0.183 | Phosphodiesterase 4C inhibitor | 0.183 0.005 CID_44266508 0.124 0.01 CID_44266438 | CID_44266508 | |
| 0.162 | 0.005 | 0.162 | Liver X receptor agonist | 0.103 0.007 CID_44266508 0.143 0.005 CID_44266438 | ||
| 0.196 | 0.038 | 0.196 | Cyclin-dependent kinase 8 inhibitor | 0.142 0.087 CID_44266508 0.162 0.068 CID_44266438 | ||
| 0.158 | 0.004 | 0.158 | Liver X receptor antagonist | 0.099 0.005 CID_44266508 0.154 0.004 CID_44266438 | ||
| 0.155 | 0.003 | 0.155 | Corticotropin releasing factor 2 receptor antagonist | 0.079 0.018 CID_44266508 0.069 0.03 CID_44266438 | ||
| 0.154 | 0.006 | 0.178 | Bromodomain-containing protein 4 inhibitor | 0.178 0.005 CID_44266508 0.093 0.015 CID_44266438 | CID_44266508 | |
| 0.165 | 0.017 | 0.165 | Janus tyrosine kinase 2 inhibitor | 0.117 0.03 CID_44266438 | ||
| 0.155 | 0.019 | 0.155 | ALK inhibitor | 0.078 0.062 CID_44266508 0.104 0.038 CID_44266438 | ||
| 0.215 | 0.082 | 0.215 | Peptidyltransferase inhibitor | 0.189 0.113 CID_44266508 0.215 0.082 CID_44266438 | ||
| 0.208 | 0.077 | 0.208 | MAP kinase kinase 2 inhibitor | |||
| 0.225 | 0.096 | 0.225 | Tyrosine 3 hydroxylase inhibitor | 0.201 0.134 CID_44266508 0.212 0.115 CID_44266438 | ||
| 0.131 | 0.004 | 0.131 | Liver X receptor beta agonist | 0.038 0.017 CID_44266508 0.131 0.004 CID_44266438 | ||
| 0.152 | 0.028 | 0.152 | Ca(v)2.2 blocker | |||
| 0.209 | 0.086 | 0.209 | Potassium channel blocker | |||
| 0.174 | 0.052 | 0.174 | CDC-like kinase 1 inhibitor | 0.111 0.105 CID_44266438 | ||
| 0.168 | 0.047 | 0.278 | Phosphodiesterase inhibitor | 0.278 0.018 CID_44266508 0.19 0.038 CID_44266438 | CID_44266508 | |
| 0.133 | 0.016 | 0.133 | Bromodomain-containing protein 2 inhibitor | 0.088 0.06 CID_44266438 | ||
| 0.192 | 0.075 | 0.192 | Focal adhesion kinase 2 inhibitor | |||
| 0.12 | 0.004 | 0.12 | Glucose-dependent insulinotropic receptor agonist | 0.055 0.009 CID_44266508 0.093 0.004 CID_44266438 | ||
| 0.14 | 0.023 | 0.14 | Leucine-rich repeat kinase 2 inhibitor | 0.089 0.05 CID_44266438 | ||
| 0.15 | 0.034 | 0.15 | Interleukin 8 antagonist | 0.123 0.058 CID_44266508 0.111 0.075 CID_44266438 | ||
| 0.126 | 0.011 | 0.126 | Transforming growth factor antagonist | 0.063 0.059 CID_44266438 | ||
| 0.126 | 0.012 | 0.316 | Phosphodiesterase 4A inhibitor | 0.316 0.005 CID_44266508 0.164 0.009 CID_44266438 | CID_44266508 | |
| 0.133 | 0.019 | 0.133 | MAP kinase 10 inhibitor | 0.079 0.052 CID_44266438 | ||
| 0.117 | 0.003 | 0.159 | Liver X receptor beta antagonist | 0.054 0.007 CID_44266508 0.159 0.003 CID_44266438 | CID_44266438 | |
| 0.116 | 0.005 | 0.13 | Liver X receptor alpha agonist | 0.05 0.019 CID_44266508 0.13 0.004 CID_44266438 | CID_44266438 | |
| 0.168 | 0.057 | 0.236 | Heat shock protein 90 antagonist | 0.236 0.025 CID_44266508 | CID_44266508 | |
| 0.161 | 0.05 | 0.161 | Sodium channel blocker | 0.134 0.071 CID_44266438 | ||
| 0.124 | 0.016 | 0.124 | Nav1.7 sodium channel blocker | 0.113 0.019 CID_44266438 | ||
| 0.2 | 0.092 | 0.2 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.174 0.11 CID_44266438 | ||
| 0.131 | 0.023 | 0.131 | Janus tyrosine kinase 3 inhibitor | 0.087 0.04 CID_44266438 | ||
| 0.19 | 0.084 | 0.19 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.13 CID_44266438 | ||
| 0.105 | 0.005 | 0.105 | Transcription factor RelA inhibitor | 0.091 0.01 CID_44266508 0.063 0.046 CID_44266438 | ||
| 0.162 | 0.064 | 0.162 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.141 0.082 CID_44266438 | ||
| 0.125 | 0.028 | 0.125 | ABCA1 expression enhancer | 0.093 0.06 CID_44266508 0.119 0.032 CID_44266438 | ||
| 0.193 | 0.096 | 0.193 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.145 | 0.048 | 0.145 | Aurora-B kinase inhibitor | 0.097 0.086 CID_44266438 | ||
| 0.114 | 0.021 | 0.114 | Focal adhesion kinase 1 inhibitor | 0.085 0.044 CID_44266508 0.091 0.038 CID_44266438 | ||
| 0.249 | 0.155 | 0.249 | GABA C receptor rho-3 antagonist | |||
| 0.095 | 0.004 | 0.1 | Liver X receptor alpha antagonist | 0.059 0.005 CID_44266508 0.1 0.004 CID_44266438 | CID_44266438 | |
| 0.133 | 0.045 | 0.133 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.149 | 0.061 | 0.161 | MAP3K9 inhibitor | 0.161 0.046 CID_44266438 | CID_44266438 | |
| 0.133 | 0.048 | 0.133 | Aurora-A kinase inhibitor | |||
| 0.114 | 0.029 | 0.114 | I kappa B kinase inhibitor | 0.093 0.045 CID_44266438 | ||
| 0.095 | 0.011 | 0.095 | Transforming growth factor beta 1 antagonist | |||
| 0.094 | 0.011 | 0.094 | MAP kinase kinase 9 inhibitor | 0.059 0.033 CID_44266438 | ||
| 0.106 | 0.025 | 0.106 | Tyk2 inhibitor | 0.079 0.037 CID_44266438 | ||
| 0.142 | 0.063 | 0.142 | Interleukin 1 antagonist | 0.113 0.1 CID_44266438 | ||
| 0.086 | 0.009 | 0.086 | DNA helicase inhibitor | 0.079 0.012 CID_44266508 0.082 0.01 CID_44266438 | ||
| 0.122 | 0.045 | 0.122 | Cyclin-dependent kinase 9 inhibitor | 0.111 0.052 CID_44266508 0.092 0.073 CID_44266438 | ||
| 0.077 | 0.002 | 0.117 | CC chemokine 9 receptor antagonist | 0.117 0.001 CID_44266508 0.033 0.003 CID_44266438 | CID_44266508 | |
| 0.09 | 0.016 | 0.09 | CC chemokine 2 receptor antagonist | 0.067 0.027 CID_44266438 | ||
| 0.098 | 0.024 | 0.098 | I kappa B kinase 1 inhibitor | 0.064 0.057 CID_44266508 0.067 0.052 CID_44266438 | ||
| 0.083 | 0.01 | 0.083 | Aldosterone antagonist | 0.047 0.034 CID_44266508 | ||
| 0.148 | 0.077 | 0.148 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.083 | 0.013 | 0.083 | Glutamate (mGluR5) antagonist | |||
| 0.138 | 0.069 | 0.138 | Cyclin-dependent kinase 7 inhibitor | 0.126 0.08 CID_44266438 | ||
| 0.129 | 0.061 | 0.129 | TRKA antagonist | 0.111 0.076 CID_44266438 | ||
| 0.096 | 0.03 | 0.096 | Cannabinoid receptor antagonist | |||
| 0.137 | 0.073 | 0.137 | Cytokine production inhibitor | |||
| 0.142 | 0.079 | 0.144 | MAP kinase kinase 4 inhibitor | 0.144 0.075 CID_44266438 | CID_44266438 | |
| 0.166 | 0.103 | 0.166 | I kappa B kinase epsilon inhibitor | |||
| 0.142 | 0.079 | 0.142 | Hemostatic | 0.131 0.094 CID_44266438 | ||
| 0.098 | 0.037 | 0.098 | Porphobilinogen synthase inhibitor | 0.075 0.052 CID_44266438 | ||
| 0.128 | 0.067 | 0.128 | Glutamate receptor antagonist | |||
| 0.088 | 0.028 | 0.088 | MAP kinase kinase 8 inhibitor | 0.073 0.041 CID_44266438 | ||
| 0.133 | 0.075 | 0.133 | Toll-Like receptor 9 antagonist | |||
| 0.093 | 0.036 | 0.093 | Rho-associated kinase I inhibitor | 0.09 0.038 CID_44266508 | ||
| 0.078 | 0.024 | 0.078 | I kappa B kinase 2 inhibitor | 0.06 0.047 CID_44266438 | ||
| 0.07 | 0.015 | 0.074 | Smo receptor antagonist | 0.074 0.014 CID_44266438 | CID_44266438 | |
| 0.187 | 0.132 | 0.19 | Cardiotonic | 0.19 0.128 CID_44266438 | CID_44266438 | |
| 0.128 | 0.074 | 0.128 | Toll-Like receptor antagonist | 0.115 0.092 CID_44266438 | ||
| 0.084 | 0.031 | 0.084 | Secretase beta inhibitor | |||
| 0.123 | 0.071 | 0.123 | MAP kinase kinase inhibitor | 0.123 0.071 CID_44266438 | ||
| 0.122 | 0.069 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.032 CID_44266508 0.111 0.092 CID_44266438 | CID_44266508 | |
| 0.128 | 0.076 | 0.128 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.079 | 0.028 | 0.079 | Cannabinoid CB1 receptor antagonist | |||
| 0.057 | 0.006 | 0.057 | ATR kinase inhibitor | 0.031 0.028 CID_44266508 0.036 0.017 CID_44266438 | ||
| 0.089 | 0.04 | 0.089 | Rho-associated kinase inhibitor | 0.069 0.056 CID_44266508 | ||
| 0.056 | 0.007 | 0.056 | Cathepsin F inhibitor | 0.054 0.009 CID_44266508 0.051 0.011 CID_44266438 | ||
| 0.089 | 0.042 | 0.089 | Glutamate (mGluR) antagonist | |||
| 0.206 | 0.16 | 0.206 | Caspase 3 stimulant | 0.204 0.164 CID_44266438 | ||
| 0.084 | 0.038 | 0.084 | Protein kinase B beta inhibitor | |||
| 0.106 | 0.061 | 0.112 | MAP kinase kinase kinase inhibitor | 0.112 0.056 CID_44266508 | CID_44266508 | |
| 0.117 | 0.073 | 0.117 | MAP kinase 12 inhibitor | |||
| 0.07 | 0.026 | 0.074 | GABA A receptor antagonist | 0.057 0.033 CID_44266508 0.074 0.024 CID_44266438 | CID_44266438 | |
| 0.108 | 0.067 | 0.108 | 5 Hydroxytryptamine 3A agonist | |||
| 0.094 | 0.054 | 0.118 | Potassium channel activator | 0.118 0.034 CID_44266508 | CID_44266508 | |
| 0.086 | 0.046 | 0.086 | Transforming growth factor beta 3 antagonist | |||
| 0.044 | 0.005 | 0.044 | Hexokinase stimulant | 0.04 0.005 CID_44266438 | ||
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.077 | 0.04 | 0.077 | Glutamate (mGluR group I) antagonist | |||
| 0.097 | 0.06 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.056 CID_44266438 | CID_44266438 | |
| 0.07 | 0.034 | 0.07 | Janus tyrosine kinase 1 inhibitor | |||
| 0.051 | 0.016 | 0.051 | Alpha 1d adrenoreceptor agonist | |||
| 0.149 | 0.114 | 0.149 | Clk dual-specificity kinase inhibitor | |||
| 0.037 | 0.004 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.016 0.014 CID_44266438 | ||
| 0.105 | 0.073 | 0.105 | MAP kinase 13 inhibitor | |||
| 0.136 | 0.104 | 0.136 | CDC-like kinase 2 inhibitor | |||
| 0.036 | 0.004 | 0.036 | Sodium/hydrogen exchanger inhibitor | 0.026 0.005 CID_44266508 0.022 0.007 CID_44266438 | ||
| 0.06 | 0.029 | 0.06 | Cannabinoid CB2 receptor antagonist | |||
| 0.061 | 0.031 | 0.068 | GABA receptor antagonist | 0.052 0.042 CID_44266508 0.068 0.026 CID_44266438 | CID_44266438 | |
| 0.079 | 0.049 | 0.079 | CYP2A6 inhibitor | |||
| 0.191 | 0.162 | 0.191 | Gastrin inhibitor | |||
| 0.124 | 0.096 | 0.124 | CC chemokine 6 receptor antagonist | |||
| 0.129 | 0.102 | 0.129 | Tyrosine kinase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Bromodomain-containing protein 3 inhibitor | |||
| 0.077 | 0.054 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.053 | 0.03 | 0.053 | Alpha 1b adrenoreceptor agonist | |||
| 0.091 | 0.069 | 0.091 | Phosphodiesterase 7B inhibitor | |||
| 0.055 | 0.035 | 0.055 | Prostaglandin antagonist | 0.054 0.036 CID_44266438 | ||
| 0.046 | 0.027 | 0.05 | Glutamate (mGluR group III) agonist | 0.05 0.024 CID_44266438 | CID_44266438 | |
| 0.039 | 0.022 | 0.039 | Growth hormone secretagogue receptor antagonist | |||
| 0.165 | 0.152 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.035 | 0.024 | 0.035 | Glycine transporter 1 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.059 | 0.047 | 0.059 | Transcription factor AP-1 inhibitor | |||
| 0.063 | 0.053 | 0.063 | MAP kinase kinase 10 inhibitor | |||
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.098 | 0.089 | 0.12 | Nav1.5 sodium channel blocker | 0.12 0.055 CID_44266438 | CID_44266438 | |
| 0.053 | 0.045 | 0.053 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.052 | 0.045 | 0.053 | Phosphodiesterase II inhibitor | 0.053 0.043 CID_44266438 | CID_44266438 | |
| 0.032 | 0.025 | 0.032 | Transforming growth factor beta 2 antagonist | |||
| 0.063 | 0.057 | 0.063 | ZAP-70 protein tyrosine kinase inhibitor | 0.063 0.057 CID_44266438 | ||
| 0.07 | 0.064 | 0.07 | Fibroblast growth factor 3 antagonist | |||
| 0.035 | 0.03 | 0.072 | Factor X inhibitor | 0.072 0.015 CID_44266508 | CID_44266508 | |
| 0.052 | 0.046 | 0.052 | Potassium channel Kv1.5 blocker | |||
| 0.106 | 0.101 | 0.106 | Tyrosine-protein kinase receptor antagonist | |||
| 0.11 | 0.106 | 0.11 | Protein kinase C nu inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.034 | 0.032 | 0.041 | ATM kinase inhibitor | 0.041 0.015 CID_44266438 | CID_44266438 | |
| 0.067 | 0.068 | 0.258 | CC chemokine receptor antagonist | 0.258 0.007 CID_44266508 | CID_44266508 | |
| 0.036 | 0.038 | 0.037 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.034 CID_44266438 | CID_44266438 | |
| 0.042 | 0.044 | 0.063 | Benzodiazepine inverse agonist | 0.053 0.021 CID_44266508 0.063 0.013 CID_44266438 | CID_44266438 | |
| 0.081 | 0.085 | 0.243 | Chemokine receptor antagonist | 0.243 0.012 CID_44266508 | CID_44266508 | |
| 0.025 | 0.032 | 0.032 | MAP3K8 inhibitor | 0.032 0.015 CID_44266508 | CID_44266508 | |
| 0.01 | 0.02 | 0.018 | 5 Lipoxygenase activating protein inhibitor | 0.018 0.005 CID_44266438 | CID_44266438 | |
| 0.077 | 0.092 | 0.122 | DNA directed RNA polymerase inhibitor | 0.122 0.036 CID_44266508 | CID_44266508 | |
| 0.039 | 0.055 | 0.076 | Thromboxane antagonist | 0.076 0.022 CID_44266438 | CID_44266438 | |
| 0.053 | 0.07 | 0.064 | Syk tyrosine kinase inhibitor | 0.064 0.056 CID_44266438 | CID_44266438 | |
| 0.053 | 0.07 | 0.065 | Bcl-xL inhibitor | 0.065 0.028 CID_44266438 | CID_44266438 | |
| 0.043 | 0.062 | 0.053 | EphB4 antagonist | 0.053 0.047 CID_44266438 | CID_44266438 | |
| 0.031 | 0.058 | 0.066 | Thromboxane A2 antagonist | 0.066 0.024 CID_44266438 | CID_44266438 | |
| 0.027 | 0.055 | 0.042 | Factor Xa inhibitor | 0.042 0.035 CID_44266508 | CID_44266508 | |
| 0.026 | 0.055 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 CID_44266438 | CID_44266438 | |
| 0.029 | 0.066 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 CID_44266438 | CID_44266438 | |
| 0.03 | 0.067 | 0.043 | AMPA receptor antagonist | 0.043 0.039 CID_44266438 | CID_44266438 | |
| 0.07 | 0.117 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 CID_44266508 | CID_44266508 | |
| 0.134 | 0.181 | 0.426 | Tumour necrosis factor alpha release inhibitor | 0.426 0.023 CID_44266508 | CID_44266508 | |
| 0.059 | 0.112 | 0.073 | Viral attachment inhibitor | 0.073 0.066 CID_44266508 | CID_44266508 | |
| 0.037 | 0.104 | 0.064 | HIV-1 reverse transcriptase inhibitor | 0.064 0.055 CID_44266508 | CID_44266508 | |
| 0.027 | 0.117 | 0.053 | H+/K+-transporting ATPase inhibitor | 0.053 0.033 CID_44266508 | CID_44266508 | |
| 0.079 | 0.188 | 0.288 | Anticoagulant | 0.288 0.03 CID_44266508 | CID_44266508 | |
| 0.049 | 0.165 | 0.117 | Platelet activating factor antagonist | 0.117 0.065 CID_44266508 | CID_44266508 | |
| 0.047 | 0.173 | 0.172 | Bronchodilator | 0.172 0.024 CID_44266508 0.098 0.066 CID_44266438 | CID_44266508 | |
| 0.007 | 0.152 | 0.042 | Plasma kallikrein inhibitor | 0.042 0.016 CID_44266508 | CID_44266508 | |
| 0.109 | 0.26 | 0.182 | Hypoglycemic | 0.182 0.131 CID_44266438 | CID_44266438 | |
| 0.018 | 0.178 | 0.071 | Kallikrein inhibitor | 0.071 0.018 CID_44266508 | CID_44266508 | |
| 0.02 | 0.212 | 0.084 | MAP kinase 11 inhibitor | 0.084 0.045 CID_44266508 | CID_44266508 | |
| 0.021 | 0.223 | 0.08 | Leukotriene synthesis inhibitor | 0.08 0.038 CID_44266438 | CID_44266438 | |
| 0.023 | 0.246 | 0.128 | Factor IXa inhibitor | 0.128 0.005 CID_44266508 | CID_44266508 | |
| 0.008 | 0.247 | 0.034 | Oxytocin antagonist | 0.034 0.033 CID_44266508 | CID_44266508 | |
| 0.093 | 0.379 | 0.224 | Immunomodulator | 0.224 0.138 CID_44266438 | CID_44266438 | |
| 0.008 | 0.304 | 0.152 | Factor XIa inhibitor | 0.152 0.004 CID_44266508 | CID_44266508 | |
| 0.006 | 0.396 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.021 CID_44266508 | CID_44266508 | |
| 0.004 | 0.465 | 0.056 | Factor XI inhibitor | 0.056 0.008 CID_44266508 | CID_44266508 | |
| 0.018 | 0.658 | 0.265 | Vasodilator | 0.265 0.062 CID_44266508 | CID_44266508 | |
| 0.067 | 0.834 | 0.462 | Calcium channel L-type activator | 0.462 0.045 CID_44266438 | CID_44266438 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |